GEN in the 13F filings
Nortonlifelock Inc · CUSIP 668771108
- Quarter end
- 30 Sep 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 12 Nov 2024
- Managers listing it
- 12
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q2 2024 and Q3 2024; 9 listed it in both
- Shares listed
- 79,690,056
- combined, among listed positions
- Reported value
- $2.2bn
- combined, at the quarter end
Among the 94 comparable managers: 6 buyers (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing GEN in Q3 2024
12 of 12 holders
Largest increases and reductions, by shares
Increases
- Neuberger Berman Group LLCexisting position · 2,520,619 shares now+40,502
- Bridgewater Associates LPexisting position · 517,591 shares now+39,609
- Caxton Associates LLPnew position · 36,670 shares now+36,670
- Brevan Howard Capital Management LPexisting position · 75,710 shares now+7,711
Reductions
- Fidelity (FMR LLC)existing position · 37,706,870 shares now-5,646,083
- AllianceBernstein LPexisting position · 10,104,953 shares now-2,276,375
- T. Rowe Price Associates Incexisting position · 7,708,632 shares now-104,947
- Tudor Investment Corpexisting position · 363,304 shares now-101,076
- GAMCO Investors Incexisting position · 88,790 shares now-700
New positions and exits
New (1)
Exited (1)
- Winton Group Ltdwas $17m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2019 | 1 | $48m | n.a. | n.a. |
| Q4 2019 | 23 | $4.2bn | n.a. | n.a. |
| Q1 2020 | 19 | $2.9bn | n.a. | n.a. |
| Q2 2020 | 16 | $3.0bn | n.a. | n.a. |
| Q3 2020 | 15 | $3.3bn | n.a. | n.a. |
| Q4 2020 | 14 | $3.3bn | n.a. | n.a. |
| Q1 2021 | 16 | $3.3bn | n.a. | n.a. |
| Q2 2021 | 20 | $4.4bn | n.a. | n.a. |
| Q3 2021 | 17 | $4.2bn | n.a. | n.a. |
| Q4 2021 | 18 | $3.9bn | n.a. | n.a. |
| Q1 2022 | 12 | $3.7bn | n.a. | n.a. |
| Q2 2022 | 17 | $2.4bn | n.a. | n.a. |
| Q3 2022 | 11 | $1.7bn | n.a. | n.a. |
| Q4 2022 | 11 | $1.7bn | n.a. | n.a. |
| Q1 2023 | 9 | $1.4bn | n.a. | n.a. |
| Q2 2023 | 12 | $1.7bn | n.a. | n.a. |
| Q3 2023 | 12 | $1.6bn | n.a. | n.a. |
| Q4 2023 | 14 | $2.1bn | 9 | 4 |
| Q1 2024 | 12 | $2.3bn | 8 | 4 |
| Q2 2024 | 12 | $2.5bn | 5 | 8 |
| Q3 2024 | 12 | $2.2bn | 6 | 6 |
| Q4 2024 | 11 | $2.0bn | 4 | 7 |
| Q1 2025 | 10 | $2.0bn | 6 | 2 |
| Q2 2025 | 10 | $2.1bn | 7 | 3 |
| Q3 2025 | 8 | $1.9bn | 4 | 4 |
| Q4 2025 | 9 | $1.9bn | 18 | 11 |
| Q1 2026 | 7 | $1.4bn | 19 | 16 |
| Q2 2026 | 6 | $1.7bn | 13 | 20 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GEN and GOOGL →GEN and AMZN →GEN and MSFT →Choose a stock to compare with GEN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GEN, latest filings →Back to the 13F Explorer →